India has grown into a major player in the pharma manufacturing sector and the scale and distribution of operations can be seen on the maps below. The maps were put together using 2007 data from the Directory of Pharmaceutical Manufacturing Units in India .
Note – since publication some people have questioned the accuracy of the Indian National Pharmaceutical Pricing Authority (NPPA) data used in the visualisations (see comment section). in-PharmaTechnologist is currently investigating the accuracy of the data.
Update 2nd June 2010 - the NPPA is in the process of finalising a new census of the Indian pharma industry. in-PharmaTechnologist plans to publish a new map when this becomes available.
Maharashtra is clearly the dominant force in both formulation and bulk drugs which is in keeping with its position as India’s leading industrial estate. Gujarat trails Maharashtra in both bulk drug and formulation but beyond this the situation is more varied.
For example, West Bengal has the third most formulation facilities, 694, but relatively few bulk drugs sites, with seven states having more of these plants. This is visualised on the chart below.